Stat Consult Slideshows

Ipilimumab (Yervoy)

Ipilimumab (Yervoy)

This slideshow reviews ipilimumab (Yervoy), for the treatment of unresectable or metastatic melanoma.

Obinutuzumab (Gazyva)

Obinutuzumab (Gazyva)

This slideshow reviews obinutuzumab (Gazyva), for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL), in combination with ...

Methylnaltrexone (Relistor)

Methylnaltrexone (Relistor)

This slideshow reviews methylnaltrexone (Relistor), for the treatment of constipation caused by narcotic medication for patients with advanced illness who ...

Imatinib (Gleevec)

Imatinib (Gleevec)

This slideshow examines imatinib (Gleevec), indicated for Philadelphia chromosome positive chronic myeloid leukemia and relapsed Philadelphia chromosome positive acute lymphoblastic ...

Asparaginase erwinia chrysanthemi (Erwinaze)

Asparaginase erwinia chrysanthemi (Erwinaze)

This slideshow reviews asparaginase erwinia chrysanthemi (Erwinaze), indicated for treatment acute lymphoblastic leukemia (ALL) in patients with a hypersensitivity to ...

Gemcitabine (Gemzar)

Gemcitabine (Gemzar)

This slideshow reviews gemcitabine (Gemzar), for the treatment of advanced ovarian cancer or for treatment for first-line treatment of metastatic ...

Brentuximab vedotin (Adcetris)

Brentuximab vedotin (Adcetris)

This slideshow reviews brentuximab vedotin (Adcetris), indicated for treatment of Hodgkin lymphoma (HL) after failure of autologous stem cell transplant ...

Cabazitaxel (Jevtana)

Cabazitaxel (Jevtana)

This slideshow reviews cabazitaxel (Jevtana), indicated, in combination with prednisone, for the treatment of hormone refractory metastatic prostate cancer in ...

Tbo-filgrastim (Granix)

Tbo-filgrastim (Granix)

This slideshow reviews Tbo-filgrastim (Granix), indicated for reduction in the duration of severe neutropenia in patients with non-myeloid malignancies receiving ...

Vemurafenib (Zelboraf)

Vemurafenib (Zelboraf)

This slideshow reviews vemurafenib (Zelboraf), indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E mutation.

Ofatumumab (Arzerra)

Ofatumumab (Arzerra)

This slideshow reviews ofatumumab (Arzerra), indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) refractory to fludarabine and ...

Vincristine

Vincristine

This slideshow reviews vincristine, indicated for Hodgkin disease, Kaposi sarcoma, leukemia, neuroblastoma, non-Hodgkin lymphoma, rhabdomyosarcoma, and Wilms' tumor.

Paclitaxel protein-bound particles (Abraxane)

Paclitaxel protein-bound particles (Abraxane)

This slideshow reviews paclitaxel protein-bound particles (Abraxane), indicated for metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer, ...

Pazopanib (Votrient)

Pazopanib (Votrient)

This slideshow reviews pazopanib, indicated for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma.

Azacitidine (Vidaza)

Azacitidine (Vidaza)

This slideshow reviews azacitidine (Vidaza), Indicated for the treatment of French-American-British (FAB) myelodysplastic syndrome subtypes.

Bendamustine (Treanda)

Bendamustine (Treanda)

This slideshow examines bendamustine (Treanda), indicated for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL).

Afatinib (Gilotrif)

Afatinib (Gilotrif)

This slideshow reviews afatinib (Gilotrif) for the treatment of non-small cell lung cancer (NSCLC).

Pertuxumab (Perjeta)

Pertuxumab (Perjeta)

This slideshow reviews Pertuxumab (Perjeta) for the treatment of HER2-positive metastatic breast cancer in combination with trastuzumab (Herceptin) and docetaxel ...

Tamoxifen

Tamoxifen

This slideshow reviews Tamoxifen for the treatment of metastatic breast cancer in women and men

Glucarpidase (Voraxaze)

Glucarpidase (Voraxaze)

This slideshow reviews Glucarpidase (Voraxaze) for the treatment of toxic plasma methotrexate concentrations (>1 μmol/L) in patients with delayed methotrexate ...

Stat Consult Articles

Ipilimumab (Yervoy)

Ipilimumab (Yervoy)

Ipilimumab is a recombinant, human cytotoxic T-lymphocyte antigen 4-blocking monoclonal antibody indicated for the treatment of unresectable or metastatic melanoma.

Oxaliplatin (Eloxatin)

Oxaliplatin (Eloxatin)

Oxaliplatin is a platinum-containing antineoplastic agent used to treat lymph node positive colorectal carcinoma and metastatic colorectal cancer.

Fluorouracil IV (5-FU, Adrucil)

Fluorouracil IV (5-FU, Adrucil)

Fluorouracil is an antimetabolite antineoplastic agent indicated for colorectal, gastric, metastatic breast, metastatic colorectal, and pancreatic cancers.

Cisplatin (Platinol, Platinol-AQ)

Cisplatin (Platinol, Platinol-AQ)

Cisplatin is a platinum-containing, aklylating agent. It is often used in combination with other chemotherapy agents as well as monotherapy because of its relative lack of hematologic toxicity.

Erlotinib (Tarceva)

Erlotinib (Tarceva)

Erlotinib is a human epidermal growth factor receptor type 1/epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor approved for non-small cell lung cancer and pancreatic cancer.

Zoledronic acid (zoledronate, Zometa)

Zoledronic acid (zoledronate, Zometa)

Zoledronic acid is a third-generation bisphosphonate prescribed to reduce pain from bony metastases, treat hypercalcemia of malignancy, and manage osteolytic lesions in multiple myeloma.

Doxorubicin

Doxorubicin

Doxorubicin is an anthracycline antibiotic that is used to treat lymphoblastic and acute myeloblastic leukemias, several types of cancer, Kaposi sarcoma related to AIDS, malignant lymphoma, soft tissue and osteogenic sarcomas, and Wilms tumor.

Arsenic trioxide (Trisenox)

Stat Consult provides rapid reviews of important drugs used in oncology.

Trastuzumab (Herceptin)

Stat Consult provides rapid reviews of important drugs used in oncology.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs